Skip to content

OS Therapies OSTX Other Non-Current Assets

Other Non-Current Assets at other companies

Immunome logo
ImmunomeIMNM
$5.36M+23.4%
CTO
Citius Oncology, Inc.CTOR
$71.28M-2.9%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$61M-14.1%
WHW
Whitehawk Therapeutics, Inc. Common StockWHWK
$1.68M+23.3%

Other financials

Income statement

See full
Operating income-$10.2M-103%
Net income-$10.4M-168%
EPS (diluted)-$0.27-50.0%

Balance sheet

See full
Cash & equivalents$917.6K-69.1%
Total debt$20.0M
Total equity-$10.8M-159%
Total assets$7.3M+71.7%

Cash flow

See full
Operating cash flow-$4.6M-32.6%
CapEx$316.4K
Free cash flow-$3.7M

Valuation

See full
Market cap$84.62M+65.5%
Enterprise value$103.7M

Returns & leverage

See full
Return on equity470%
Debt / equity-1.8×
Current ratio0.1×-1.1×

Where this comes from

Reported directly by OS Therapies in its filing.

Tagged under the XBRL concept us-gaap:DepositsAssetsNoncurrent.

The official record: OS Therapies’s 10-Q, filed May 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about OS Therapies's other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OS Therapies's other non-current assets?
OS Therapies (OSTX) reported other non-current assets of $6.38M in Q1 2026.
How has OS Therapies's other non-current assets changed year-over-year?
OS Therapies's other non-current assets increased by 4153.3% year-over-year, from $150K to $6.38M.
What does other non-current assets mean?
Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.